TOPPER JAMES N purchased 6.8% of their position (3.78K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $14.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/23/2025ACC: 0001415889-25-014428
Director10% Owner
Since Oct 2019
+3.78K
Net shares
Net buyer
$14.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.78K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+3.78K
Price / share
$3.86
Trade value
$14.61K
% of position
6.8%
5/21/2025
55.62K→59.40K
Total
Net shares
+3.78K
Net value
$14.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/21/2025 | P · Purchase | +3.78K | $3.86 | $14.61K | 6.8% | 55.62K | 59.40K |
| Total | +3.78K | $14.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.00
Common Stock
IndirectShares owned5.83M
Common Stock
IndirectShares owned3.91K
Common Stock
DirectShares owned32.10K
Total
32.10K direct·5.83M indirect5.86M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.00 | Indirect |
| Common Stock | 5.83M | Indirect |
| Common Stock | 3.91K | Indirect |
| Common Stock | 32.10K | Direct |
| Total | 5.86M | 32.10K direct·5.83M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported